These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22350222)

  • 1. Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency.
    Booth C; Algar VE; Xu-Bayford J; Fairbanks L; Owens C; Gaspar HB
    J Clin Immunol; 2012 Jun; 32(3):449-53. PubMed ID: 22350222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).
    Kohn DB; Gaspar HB
    J Clin Immunol; 2017 May; 37(4):351-356. PubMed ID: 28194615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.
    Nikolajeva O; Worth A; Hague R; Martinez-Alier N; Smart J; Adams S; Davies EG; Gaspar HB
    J Clin Immunol; 2015 May; 35(4):366-72. PubMed ID: 25875700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
    Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
    J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.
    Forbes EM; McNaughton PB
    J Clin Immunol; 2024 Jul; 44(7):162. PubMed ID: 39008132
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency.
    Kohn DB; Hershfield MS; Puck JM; Aiuti A; Blincoe A; Gaspar HB; Notarangelo LD; Grunebaum E
    J Allergy Clin Immunol; 2019 Mar; 143(3):852-863. PubMed ID: 30194989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulse oscillometry identifies peripheral airway dysfunction in children with adenosine deaminase deficiency.
    Komarow HD; Sokolic R; Hershfield MS; Kohn DB; Young M; Metcalfe DD; Candotti F
    Orphanet J Rare Dis; 2015 Dec; 10():159. PubMed ID: 26682746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency.
    Grunebaum E; Cutz E; Roifman CM
    J Allergy Clin Immunol; 2012 Jun; 129(6):1588-93. PubMed ID: 22409989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Outcome of Adenosine Deaminase-Deficient Patients-a Single-Center Experience.
    Scott O; Kim VH; Reid B; Pham-Huy A; Atkinson AR; Aiuti A; Grunebaum E
    J Clin Immunol; 2017 Aug; 37(6):582-591. PubMed ID: 28748310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of two SCIDs.
    Shaw KL; Kohn DB
    Sci Transl Med; 2011 Aug; 3(97):97ps36. PubMed ID: 21865536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with Elapegademase Restores Immunity in Infants with Adenosine Deaminase Deficient Severe Combined Immunodeficiency.
    Hicks ED; Hall G; Hershfield MS; Tarrant TK; Bali P; Sleasman JW; Buckley RH; Mousallem T
    J Clin Immunol; 2024 Apr; 44(5):107. PubMed ID: 38676811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
    Baffelli R; Notarangelo LD; Imberti L; Hershfield MS; Serana F; Santisteban I; Bolda F; Porta F; Lanfranchi A
    J Clin Immunol; 2015 Oct; 35(7):624-37. PubMed ID: 26376800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
    Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
    Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.
    Sauer AV; Brigida I; Carriglio N; Hernandez RJ; Scaramuzza S; Clavenna D; Sanvito F; Poliani PL; Gagliani N; Carlucci F; Tabucchi A; Roncarolo MG; Traggiai E; Villa A; Aiuti A
    Blood; 2012 Feb; 119(6):1428-39. PubMed ID: 22184407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.
    Gaspar HB; Cooray S; Gilmour KC; Parsley KL; Zhang F; Adams S; Bjorkegren E; Bayford J; Brown L; Davies EG; Veys P; Fairbanks L; Bordon V; Petropoulou T; Kinnon C; Thrasher AJ
    Sci Transl Med; 2011 Aug; 3(97):97ra80. PubMed ID: 21865538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
    Hsu AP; West RR; Calvo KR; Cuellar-Rodriguez J; Parta M; Kelly SJ; Ganson NJ; Hershfield MS; Holland SM; Hickstein DD
    J Allergy Clin Immunol; 2016 Aug; 138(2):628-630.e2. PubMed ID: 27130863
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
    Chan B; Wara D; Bastian J; Hershfield MS; Bohnsack J; Azen CG; Parkman R; Weinberg K; Kohn DB
    Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase deficiency: a review.
    Flinn AM; Gennery AR
    Orphanet J Rare Dis; 2018 Apr; 13(1):65. PubMed ID: 29690908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.